Newcastle Disease Virus LaSota Strain Kills Human Pancreatic Cancer Cells in Vitro with High Selectivity. Jan 2012 - JOP; 13(1):1590-8577 [PMID:22233946] [Walter RJ] [Attar BM] [Rafiq A] [Tejaswi S] [Delimata M]
Newcastle Disease Virus: a Promising Agent for Tumor Immunotherapy. Jan 2012 - :1440-1681 [PMID:22211810] [Zhao L] [Liu H]
Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo. Dec 2011 - :1873-5835 [PMID:22133641] [Alabsi AM] [Ali R] [Ideris A] [Omar AR] [Bejo MH] [Yusoff K] [Ali AM]
Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo. Dec 2011 - :1872-7980 [PMID:22095029] [Meng S] [Zhou Z] [Chen F] [Kong X] [Liu H] [Jiang K] [Liu W] [Hu M] [Zhang X] [Ding C] [Wu Y]
Safety and clinical usage of newcastle disease virus in cancer therapy. Dec 2011 - J. Biomed. Biotechnol.; 2011:1110-7251 [PMID:22131816] [Lam HY] [Yeap SK] [Rasoli M] [Omar AR] [Yusoff K] [Suraini AA] [Banu Alitheen N]
Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity. Nov 2011 - :1791-2423 [PMID:22102168] [Fournier P] [Arnold A] [Wilden H] [Schirrmacher V]
Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus. Oct 2011 - :1791-2423 [PMID:21971670] [Fournier P] [Wilden H] [Schirrmacher V]
Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation. Sep 2011 - Methods Mol. Biol.; 797:1940-6029 [PMID:21948477] [Fournier P] [Bian H] [Szeberényi J] [Schirrmacher V]
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer. Sep 2011 - Head Neck; 33(10):1097-0347 [PMID:21928411] [Li P] [Chen CH] [Li S] [Givi B] [Yu Z] [Zamarin D] [Palese P] [Fong Y] [Wong RJ]
Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus Sep 2011 - 2011 ASCO Annual Meeting; Oral Abstract Session, Developmental Therapeutics - Clinical Pharmacology and Immunotherapy [Nesselhut ]
Apoptin Enhances the Oncolytic Properties of Newcastle Disease Virus. Aug 2011 - :1423-0100 [PMID:21865658] [Wu Y] [Zhang X] [Wang X] [Wang L] [Hu S] [Liu X] [Meng S]
Recent Clinical Experience With Oncolytic Viruses. Aug 2011 - :1873-4316 [PMID:21740364] [Donnelly OG] [Errington-Mais F] [Prestwich R] [Harrington K] [Pandha H] [Vile R] [Melcher AA]
Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus. May 2011 - :1432-8798 [PMID:21625975] [Bian J] [Wang K] [Kong X] [Liu H] [Chen F] [Hu M] [Zhang X] [Jiao X] [Ge B] [Wu Y] [Meng S]
Oncolytic specificity of newcastle disease virus is mediated by selectivity for apoptosis-resistant cells. May 2011 - J. Virol.; 85(12):1098-5514 [PMID:21471241] [Mansour M] [Palese P] [Zamarin D]
Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity. Apr 2011 - Int. J. Oncol.; 38(6):1791-2423 [PMID:21424118] [Fournier P] [Aigner M] [Schirrmacher V]
